Caprius(CAPR), Breast MRI(former ANMR/MAMO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caprius(CAPR), Breast MRI(former ANMR/MAMO)

CAPR 5.685

+1.2%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Maxwell Fashola who wrote (2023)	10/22/1997 11:49:00 PM
From: luis a. garcia	Read Replies (2) of 2615

Maxwell the company ANMR is the parent company with 19 patents to MAMO's 1 and 1 pending on their newly approved Aurora breast MRI system. The combined company name according to Beverly is in the proxy and I glanced at it but didn't really see anything other than both these existing names... so you may be right but they said the new company would have a different name.. so I still don't know. However if you are planning to buy in AND believe the merger will go through as a lot of people do then understand ANMR stock will reverse 1 for 10 and MAMO will convert to the new stock at 40% of the position. Another way to see this in addition to intellectual property the parent comapany has 12 mill in cash and Rehab center biz it owns 100% that is good at differentiating between good and false medical claims. and the patents. And has licenced technology to MAMO for their mammography application. GE currently invested 5 million in ANMR. Then MAMO has the approved breast imaging system and a lot of debt. And needs the capital ANMR has to comercialize this product. Currently has a backlog of 1.5 mill and 500k in the works. And is undergoing multisite studies to prove to the FDA that the machines executing the time honored X-RAY standard protocol produce similar results in different locations. At that time it will apply to the FDA for approval of the validated AURORA MRI PROTOCOL that as meeting and exceeding considerably the standard xray accuracy diagnostic. and that will protect the installations from frivolous lawsuits. i.e. the machines will be as good diagnostically as xrays are today. Now then as part of the study they plan to show the machines can identify malignant cancers and avoid unnecesary biopsis at much higher percentages than xrays and that will begin to expand the boundaries of the MRI application in mammography way superior to xrays. As well as the machines being able to accurately diagnose tumors in the high 90's...99.7% (potentially) Killer rays do perhaps 70% today. So the power of the MRI scan will begin to make its presence felt in the market. If you are patient I think you can accumulate some stock and average in a position for your future. This is risky but that is why we make the big bucks ha, ha.. With GEMS as a global manufacturing and distribution and sales partner (my wet dream) I think the compnay will have its day. Also it may be accepted back to the Nasdaq which will bring in more investors.. in time.. horizon 1 to 2 years out... Of course if we sell out to GEMS it will buy the combined works for peanuts and who knows... Their first shot became something like a 22% investment in the stock of the combined entity common+preffered (rough guesstimate). Luis

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next